Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial

IF 1.5 4区医学 Q3 PSYCHIATRY

Journal of Dual Diagnosis Pub Date : 2024-04-05 DOI:10.1080/15504263.2024.2329267

Gabriel Bastien, Anita Abboud, Christina McAnulty, Laurent Elkrief, Omar Ledjiar, M. Eugenia Socias, Bernard Le Foll, Anees Bahji, Suzanne Brissette, Stéphanie Marsan, Didier Jutras-Aswad

引用次数: 0

Abstract

To evaluate the impact of depressive symptom severity on opioid use and treatment retention in individuals with prescription-type opioid use disorder (POUD).We analyzed data from a multi-centric, p...

查看原文本刊更多论文

抑郁症状严重程度对丁丙诺啡/纳洛酮和美沙酮治疗处方型阿片类药物使用障碍患者疗效的影响：务实随机对照试验的结果

评估抑郁症状严重程度对处方型阿片类药物使用障碍（POUD）患者使用阿片类药物和坚持治疗的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Dual Diagnosis Multiple-

CiteScore

4.90

自引率

13.60%

发文量

期刊介绍： Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges.